Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.

Author: BochenekW, ForsmarkC, LewE A, MetzD C, PisegnaJ R, SofferE F, StarrJ A

Paper Details 
Original Abstract of the Article :
In patients with Zollinger-Ellison syndrome (ZES) or other conditions requiring oral doses of proton pump inhibitors, it frequently becomes necessary to use parenterally administered gastric acid inhibitors. However, i.v. histamine-2 receptor antagonists are not effective at usual doses and lose the...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1572-0241.2001.05325.x

データ提供:米国国立医学図書館(NLM)

Zollinger-Ellison Syndrome: A Desert Oasis of Treatment Options

Zollinger-Ellison syndrome (ZES), a rare condition characterized by excessive gastric acid production, is like a scorching desert, causing severe stomach pain, ulcers, and other complications. This research explores the potential of intravenous pantoprazole, a proton pump inhibitor, as a treatment option for ZES, offering a glimpse into the oasis of treatment options for this challenging condition.

Intravenous Pantoprazole: A Refreshing Spring in the Desert of ZES

The researchers investigated the safety and efficacy of intravenous pantoprazole as an alternative to oral proton pump inhibitors for managing gastric acid hypersecretion in ZES. They found that intravenous pantoprazole effectively controlled gastric acid production, providing relief from the symptoms of ZES. It's like finding a refreshing spring in the desert, offering a much-needed reprieve from the scorching heat of excessive acid production.

Navigating the Desert of ZES Treatment

This study provides valuable insights for managing ZES. It demonstrates the effectiveness of intravenous pantoprazole as a treatment option, offering a potential oasis for patients with this challenging condition. However, it's important to remember that ZES is a complex condition, and treatment decisions should be made in consultation with a healthcare professional. Like a wise desert traveler, rely on the guidance of experienced medical professionals to navigate the complexities of this disease.

Dr.Camel's Conclusion

This study highlights the potential of intravenous pantoprazole as an effective treatment option for Zollinger-Ellison syndrome. While more research is needed to fully understand its long-term efficacy and safety, this drug offers a potential oasis of relief for patients struggling with this challenging condition. As we continue to explore the desert landscape of ZES treatment, we can offer more personalized and effective solutions for patients, ensuring their journey toward health and well-being.

Date :
  1. Date Completed 2002-01-16
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

11774936

DOI: Digital Object Identifier

10.1111/j.1572-0241.2001.05325.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.